APELLIS PHARMACEUTICALS INC's ticker is and the CUSIP is 03753U906. A total of 5 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $10,342,000 | -24.3% | 200,000 | 0.0% | 0.53% | -32.4% |
| Q3 2022 | $13,660,000 | +51.0% | 200,000 | 0.0% | 0.79% | +50.5% |
| Q2 2022 | $9,044,000 | -11.0% | 200,000 | 0.0% | 0.52% | +59.1% |
| Q1 2022 | $10,162,000 | +19.0% | 200,000 | -22.8% | 0.33% | +26.9% |
| Q3 2021 | $8,540,000 | – | 259,100 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PURA VIDA INVESTMENTS, LLC | 200,000 | $9,044,000 | 0.52% |
| GROUP ONE TRADING, L.P. | 49,500 | $2,238,000 | 0.00% |
| JANE STREET GROUP, LLC | 148,500 | $6,715,000 | 0.00% |
| SIMPLEX TRADING, LLC | 44,700 | $2,021,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |